Biomarkers: How to consolidate them in clinical practice

被引:0
作者
Prous, Maria Jesus Garcia de Yebenes [1 ]
Ortells, Loreto Carmona [1 ]
机构
[1] Inst Salud Musculoesquelet InMusc, Madrid, Spain
来源
REUMATOLOGIA CLINICA | 2024年 / 20卷 / 07期
关键词
Biomarkers; Personalized medicine; Validation; Implementation; VALIDATION; DISCOVERY;
D O I
10.1016/j.reuma.2024.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An inadequate biomarker validation can affect many patients' diagnosis, treatment, and follow-up. Therefore, special interest should be placed on performing these analyses correctly so that biomarkers can be applicable to patients and evidence of their clinical usefulness can be generated. A methodological work on the concept of biomarkers is presented, as well as the difficulties associated with the methodological approach to their development, validation, and implementation in clinical practice. (c) 2024 Elsevier Espana, a, S.L.U. and Sociedad Espanola ola de Reumatolog & imath;<acute accent>a y Colegio Mexicano de Reumatolog & imath;<acute accent>a. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:386 / 391
页数:6
相关论文
共 17 条
[1]  
Aronson Jeffrey K, 2017, Curr Protoc Pharmacol, V76, DOI 10.1002/cpph.19
[2]   Biomarkers and surrogate end points-the challenge of statistical validation [J].
Buyse, Marc ;
Sargent, Daniel J. ;
Grothey, Axel ;
Matheson, Alastair ;
De Gramont, Aimery .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) :309-317
[3]   Biomarker Validation: Common Data Analysis Concerns [J].
Ensor, Joe E. .
ONCOLOGIST, 2014, 19 (08) :886-891
[4]  
European medicines agency, QUALIFICATION NOVEL
[5]  
Food and Drug Administration, Bionalytical method validation. Guidance for industry 2018
[6]  
Gimenez Mascarell P, 2014, Dianas, V3
[7]   False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies [J].
Glickman, Mark E. ;
Rao, Sowmya R. ;
Schultz, Mark R. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (08) :850-857
[8]   Biomarker validation and testing [J].
Hayes, Daniel F. .
MOLECULAR ONCOLOGY, 2015, 9 (05) :960-966
[9]   Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers [J].
Kolev, Mirjam ;
Horn, Michael P. ;
Semmo, Nasser ;
Nagler, Michael .
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2022, 5
[10]   Biomarkers as drug development tools: discovery, validation, qualification and use [J].
Kraus, Virginia B. .
NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (06) :354-362